In episode 463, James and Mike talk about the latest reports of the results of the 2 COVID-19 vaccine trials. We give you all the numbers you need to know and maybe more importantly we discuss the nuances around industry bias, the approval process and general thoughts around vaccines in… Read More
In episode 462, James and Mike invite Scott Garrison to talk about some important nuances around guideline recommendations and how low we should lower systolic blood pressure. We look in detail at the SPRINT trial and then come up with a reasonable (in our minds) approach to what thresholds we… Read More
In episode 461, James and Mike invite Tina Korownyk to talk about the important question of whether or not virtual visits are as good as face-to-face when it comes to diagnosing undifferentiated presentations. At the conclusion of this activity, participants will be able to: Explain to patients the benefits of… Read More
In episode 460, James and Mike invite Mike Kolber back again to answer the question does advising patients to abstain from alcohol reduce atrial fibrillation recurrence. The results may surprise you! At the conclusion of this activity, participants will be able to: Explain to patients the efficacy of abstention from… Read More
In episode 458, James and Mike cover a number of new and useful RCTs. We discuss 4 new Vitamin D trials, atrial fibrillation and do you need both rate and rhythm control, swollen legs and cellulitis, and is colchicine the new statin. At the conclusion of this activity, participants will… Read More
